Niu Yueyue, Xiao Lu, Feng Ling
the Cadre Health Care Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Sci Rep. 2025 Apr 30;15(1):15153. doi: 10.1038/s41598-025-99396-9.
Metabolic syndrome (MetS) poses a significant global health challenge, closely associated with cardiovascular diseases, diabetes, and other conditions. With the global prevalence of MetS steadily rising, the potential role of gut microbiota in its development has garnered increasing attention. Against this backdrop, the present study aims to explore the association between the dietary index for gut microbiota (DI-GM) score and MetS. This cross-sectional study utilized data from the 2007-2018 U.S. National Health and Nutrition Examination Survey (NHANES), including 339,242 adults aged ≥ 18 years. The DI-GM score, constructed based on 14 food or nutrient components, served as the exposure variable. MetS was defined according to the Adult Treatment Panel III (ATP III) criteria, including abdominal obesity (waist circumference ≥ 102 cm in men and ≥ 88 cm in women), elevated triglycerides (≥ 150 mg/dL), reduced HDL cholesterol (< 40 mg/dL in men and < 50 mg/dL in women), elevated blood pressure (≥ 130/85 mmHg), and elevated fasting glucose (≥ 100 mg/dL). Multivariable logistic regression analyses were performed to adjust for demographic characteristics, lifestyle factors, and other potential confounders. Higher DI-GM scores were significantly associated with a reduced risk of MetS. After adjusting for all confounders, individuals in the highest quartile (Q4) of DI-GM scores had a 16% lower risk of MetS compared to those in the lowest quartile (Q1) (OR: 0.84; 95%CI: 0.70-1.01). Mediation analyses revealed that systemic immune-inflammation index (SII) and neutrophil-to-lymphocyte ratio (NLR) mediated 4.63% and 3.83% of the association between DI-GM and MetS, respectively. There is an inverse association between DI-GM scores and the risk of MetS, potentially mediated in part by inflammatory markers. These findings provide new evidence supporting dietary interventions aimed at improving gut microbiota to prevent MetS.
代谢综合征(MetS)是一项重大的全球健康挑战,与心血管疾病、糖尿病及其他病症密切相关。随着全球代谢综合征患病率稳步上升,肠道微生物群在其发展中的潜在作用日益受到关注。在此背景下,本研究旨在探讨肠道微生物群饮食指数(DI-GM)得分与代谢综合征之间的关联。这项横断面研究利用了2007 - 2018年美国国家健康与营养检查调查(NHANES)的数据,包括339,242名年龄≥18岁的成年人。基于14种食物或营养成分构建的DI-GM得分作为暴露变量。代谢综合征根据成人治疗小组第三次报告(ATP III)标准定义,包括腹型肥胖(男性腰围≥102厘米,女性腰围≥88厘米)、甘油三酯升高(≥150毫克/分升)、高密度脂蛋白胆固醇降低(男性<40毫克/分升,女性<50毫克/分升)、血压升高(≥130/85毫米汞柱)和空腹血糖升高(≥100毫克/分升)。进行多变量逻辑回归分析以调整人口统计学特征、生活方式因素和其他潜在混杂因素。较高的DI-GM得分与代谢综合征风险降低显著相关。在调整所有混杂因素后,DI-GM得分最高四分位数(Q4)的个体与最低四分位数(Q1)的个体相比,患代谢综合征的风险低16%(比值比:0.84;95%置信区间:0.70 - 1.01)。中介分析显示,全身免疫炎症指数(SII)和中性粒细胞与淋巴细胞比值(NLR)分别介导了DI-GM与代谢综合征之间关联的4.63%和3.83%。DI-GM得分与代谢综合征风险之间存在负相关,可能部分由炎症标志物介导。这些发现为旨在改善肠道微生物群以预防代谢综合征的饮食干预提供了新证据。